EVALUATING THE EFFECTIVENESS OF SCREENING FOR CANCER IN THE POPULATION OF WORKING ABROAD AND IN KAZAKHSTAN. SYSTEMATIC REVIEW
According to the International Agency for Research on Cancer of the world, the incidence of malignant tumors found 14.1 million new cases and 8.2 million deaths identified. In 2012, the most frequently diagnosed cancer of the lung (1.82 million.), breast cancer (1.67 million), a malignant neoplasm of the rectum (1.36 million); and the most common cause of death from malignant neoplasms has been established lung cancer (1.6 million deaths), liver cancer (745,000 deaths) and stomach cancer (723,000 deaths). Early diagnosis of malignant neoplasms and timely treatment of patients significantly improved by conducting cancer screening. The results of cancer screening leads to an increase in the standard of living and on the day for today is the most effective method for early diagnosis of malignant diseases. The purpose of screening early detection and active treatment of cancer during their early development. Currently, in the Republic of Kazakhstan screening program direction for the visual detection of malignant tumors. They are breast cancer, cervical cancer and colorectal cancer. The last 2 years held onkoskrininga pilot program covers the following types of cancer; esophageal cancer, gastric, prostate, liver, and hepatocellular carcinoma. Many of the studies in this area, early detection of malignant tumors is one of the urgent problems. Over the past 10 years was studied cancer screening conducted a study to identify abroad and in the Republic of Kazakhstan and the efficiency shortcomings cancer screening population. In this work we have studied in the past 10 years of full-text publications іn anglisskom language, we have paid special attention to the age categories, the efficiency, the negative effects of screening and researchers recommendations. It was identified in 1254 sources MEDLINE database, SCOPUS, have been selected and included in the analysis 62 articles.
Мyrzatai A. Buleshov 1,2, http://orcid.org/0000-0002-7472-1703
Karlygash N. Tazhibayeva 2, http:// orcid.org/0000-0003-4947-3717
Aijan М. Buleshovа 1, http://orcid.org/0000-0001-9705-1119
Andrej M. Grjibovski 2-5, http://orcid.org/0000-0002-5464-0498
1 South-Kazakhstan State Pharmaceutical Academy, Shymkent, Kazakhstan;
2 International Kazakh-Turkish University, Turkestan, Kazakhstan;
3 Norwegian Institute of Public Health, Oslo, Norway;
4 Northern State Medical University, Arkhangelsk, Russia;
5 North-Eastern Federal University, Yakutsk, Russia.
1. Алиева Т.М. Cкрининг рака шейки матки ошибки в диагностике и пути их предупреждения // Вестник АГИУВ. 2013. С. 24-27.
2. Жылкайдарова А.Ж. Результаты скринингов злокачественных новообразований по итогам 2015 года // СКДО КазНИИОиР 2015. URL: http://onco.kz/node/14 (дата обращения: 01.01.2016)
3. Инструкция по проведению профилактических медицинских осмотро в отдельных категорий взрослого населения путем выборочных скрининговых обследованийhttp // Методическое указания. URL: Оnline.zakon.kz. (дата обращения: 01.01.2016)
4. Кайдаров Б.К., Балтаев Н.А., Афонин Г.А. Заболеваемость колоректальным раком и состояние хирургической помощи онкологическим больным с данной патологией // Онкология и радиология Казахстана. 2011. № 4. С. 37-40.
5. Комарова Л.Е. Cовременное состояние скрининговых программ в онкологии ФГБУ // Pоссийский онкологический журнал. Москва. 2013. № 5.
6. Комарова Л.Е. Современное состояние скрининговых программ в онкологии // Российский онкологический журнал. 2013. № 5. С. 48-51.
7. Каприн А.Д. Старинский В.В, Петрова Г.В. Злокачественные новообразования в России в 2012 году (заболеваемость и смертность) // Книга. ред.М: ФГБУ «МНИОИ им. П. А. Герцена» Минздрава России, 2014. C. 250.
8. Қазақстан Республикасының халқына онкологиялық көмек көрсететін денсаулық сақтау ұйымдарының қызметі туралы ережені бекіту туралы 2011 жылғы 12 тамыздағы № 540 бұйрығына өзгерістер мен толықтырулар енгізу туралы. URL: http://adilet.zan.kz/rus (дата обращения: 01.01.2016)
9. Қазақстан Республикасында онкологиялық көмекті дамытуды 2012 - 2016 жылдарға арналған бағдарламасын бекіту туралы Қазақстан Республикасы Үкіметінің 2014 жылғы 30 желтоқсандағы № 1410 қаулысы. Қазақстан. 2014. URL:https://www.google.kz/ (дата обращения: 01.01.2016)
10. Нургалиева Т.А. Выявляемость злокачественных новообразований в скрининге рака шейки матки // Наука и здравоохранения. 2012. №4. С. 80-82
11. Навесова В.Ш., Арыбжанов Д.Т., Туменбаева Ж.С., Каскабаев А.У., Маклакова Е.Э. Результаты маммографического скрининга рака молочной железы в Южном –Казахстане // Сибирский онкологический журнал. 2009. №2. С.1141-142
12. Об утверждении стандарта организа-ции оказания первичной медикосанитарной помощи в Республике Казахстан 4 марта 2016 года № 13392 Приказ. URL: https://egov.kz (дата обращения: 01.01.2016)
13. Об утверждении Правил проведения профилактических медицинских осмотров целевых групп населения // Приказ и.о. Министра здравоохранения Республики Казахстан 10 ноября 2009. № 685. URL: https://egov.kz (дата обращения: 01.01.2016)
14. Приказ Министра здравоохранения Республики Казахстан от 16 марта 2011 года №145 Об утверждении Правил проведения профилактических медицинских осмотров целевых групп населения. URL: https://egov.kz (дата обращения: 01.01.2016)
15. Рахыпбеков Т.К., Жакипова А.А., Бань Т.П. Выявляемость злокачественных ново-образований в скрининге молочной железы // Наука и здравоохранение. 2010. № 1. С. 212-214.
16. Результаты скрининга рака молочной железы по Актюбинской области за 2011 год // Батыс Қазақстан медицина журналы. 2012. №2. С. 34.
17. Турбекова М.Н., Егеубаева С.А. Современные подходы к раннему выявлению колоректального рака (литературный обзор). Вестник КАЗНМУ. 2012. №4. С.89-94.
18. Таштемирова О.Г., Тергеусизов С.М., Тергеусизова Ш.А., Таштемиров К.К., Жалтыров Р.Л., Жакупова Г.А. Роль скринингового исследования в диагностике злокачественных новообразований желудочно-кишечного тракта // Наука и здравоохранения. 2014. №4. С.94-96
19. Тажибаева К.Н. Жанабаев Н.С. Керимов Р.А. Булешов М.А. Оңтүстік Қазақстан облысында тұрғындар арасындағы онкологиялық аурулардың скрининг тәсілімен анықталуының кәзіргі таңдағы жағдайы // Вестник КазНМУ. 2015. №4. С.137-139.
20. Тургунов М.А. Центр формирования здорового образа жизни по Северо-казахстанской области. URL: http://sko-zozh.kz/skrining-raka-predstatelnoj-zhelezy-v-rk (дата обращения: 01.01.2016)
21. Холматова К.К., Харькова О.А., Гржибовский А.М. Классификация научных исследований в здравоохранении // Экология человека. 2016. № 1. С. 57–64.
22. Холматова К.К., Горбатова М.А., Харькова О.А., Гржибовский А.М. Поперечные исследования: планирование, размер выборки, анализ данных // Экология человека. 2016. № 2. С. 49–56.
23. Холматова К.К., Харькова О.А., Гржибовский А.М. Особенности применения когортных исследований в медицине и обще-ственном здравоохранении // Экология человека. 2016. № 4. С. 56–64.
24. Холматова К.К., Гржибовский А.М. Применение исследований «случай-контроль» в медицине и общественном здравоохранении // Экология человека. 2016. № 8. С. 53–60.
25. Холматова К. К., Гржибовский А. М. Панельные исследования и исследования тренда в медицине и общественном здравоохранении // Экология человека. 2016. № 10. С. 57–64.
26. Холматова К.К., Харькова О.А., Гржибовский А.М. Экспериментальные исследования в медицине и здравоохранении: планирование, обработка данных, интерпре-тация результатов // Экология человека. 2016. № 11. С. 50–58.
27. Шалгумбаева Г.М. Оценка эффектив-ности проведения скрининговой программы по раннему выявлению раковых и предраковых заболеваний шейки матки по Восточно-Казахстанскому региону и пути улучшения ее качества: автореф. дис. ... PhD доктор. Семей. 2014. 38 с.
28. Шибанова А.И., Елеубаева Ж.Б., Сабитов Д., Кашмагамбетова М.Ш., Каримова Н.Г., Жылкайдарова А.Ж. Организация скрининга рака шейки матки в Республике Казахстан и пути совершенствования // Онкология и радиология Казахстана 2016. №10. С. 53.
29. Alanbay I., Emre Karaşahin K., Ozturk M., Cemal Yenen. M. The cytohistological discrepencies of cervicovaginal smears and hpv status // ESGO eAcademy Alanbay i. 2015, Oct 24. 107109.
30. Anand SS., McLaughlin SJ., Chen F., Hayes IP., Hunter A., Skinner I.J. Pervonachalnoe impact colon cancer screening program of National Australia // Med J Aust. 2009. P. 378-81.
31. Amy J Blatt., Ronald Kennedy., Ronald D Luff. Comparison of cervical cancer screening results among 256.648 women in several clinical practice // Cancer Cytopathol. 2015. N123. (5). P. 282.
32. Andrae B., Kemetli L., Sparen P., Silfverdal L., Strander B., Ryd W., Dillner J., Törnberg S. Screening-preventable cervical cancer risk: a national audit data in Sweden // J Natl Cancer Inst 2008. N100. P.622- 629.
33. Andriole G.L., Crawford E.D., Grubb R.L. Mortality results from a randomized prostate-cancer screening trial // N Engl J Med. 2009. N360. P. 1310-1319.
34. Bretthauer M., Kalager M. Priciples effectiveness and caveats in screening for cancer // Br. J. Surg. 2013. P. 55-65.
35. Boyle P. Levin International Agency for Research on Cancer // World Report 2008 Cancer.
36. Brenner H., Hoffmeister M., Birkner B.C. Diagnosis Stock guaiac-based fecal occult blood test in routine screening: analysis of the national // Official Journal of the European Union. 2003. P. 327.
37. By Jennifer S., Margaret A., Leslie A., Carolyn M., Elizabeth M. Screening for Colorectal Cancer US Preventive Services Task Force Recommendation Statement // American Medical Association. JAMA. 2016. N315. (23). P. 2564-2575.
38. Baxter N., Meredith A. Goldwasser S. Association of Colonoscopy and Death From Colorectal Cancer. A Population-Based, Case–Control Study Nancy MPH // Annals of Internal Medicine. 2019. N1. p. 1-9.
39. Canfield S. Annual screening for prostate cancer did not reduce mortality from prostate cancer // Evid Based Med. 2009. N14. P. 104-105.
40. Dickinson J., Tsakonas E., Conner Gorber S., Lewin G.E. Canadian Task Force on Preventive Health Care. Shaw and other recommendations for screening cervical cancer // CMAJ. 2013. N185. P. 35-45.
41. European Union Council. Recommendation of 2 December 2003 on Cancer Screening, 2003 // European Union EN 2003. N12. P. 16.
42. Edwards B.K., Kohler B.A. Annual report to the nation on the state of cancer 1975-2006, featuring colorectal cancer trends and the effects of interventions // Risk factors, screening and treatment to reduce future morbidity cancer. 2010. N116. (3). P. 544-573.
43. Evelyn P., Jennifer S. Lin, Margaret Piper, Leslie A. Perdue, Carolyn M. Rutter, Elizabeth M. Webber, Elizabeth O'Connor, Ning Smith, Whitlock Screening for Colorectal Cancer US Preventive Services Task Force Recommendation Statement // American Medical Association. JAMA. 2016. N315. (23). P. 2564-2575.
44. Feb. J., Dancourt V.S. The decrease of colorectal cancer mortality using fecal occult blood screening in the French controlled study // Gastroenterology. 2004. N126. (7). P. 1674-1680.
45. Falk R.S., Hofvind S., Skaane P. Overdiagnosis among women attending a population-based mammography screening programme // Int. J. Cancer. 2013. Jan 25.
46. GLOBOCAN 2008 International Agency for Research on Cancer. Kolorektalny morbidity and mortality from cancer in the world. 2008. Available at: https://www. //globocan2008.php (accessed 01.01.2016).
47. Soerjomataram F.J., Ervik I., Dikshit M, Eser R., Mathers S. Cancer incidence and mortality worldwide // International Agency for Research on Cancer. 2016. 22 January. Available at: http://globocan.iarc.fr, accessed (accessed 01.01.2016).
48. Harald Weedon-Fekjær, Pål R Romundstad, Lars J Vatten. Modern mammography screening and breast cancer mortality // Population study BMJ. 2014. P. 348.
49. Hardcastle J.D., Chamberlain J.O., the M.H. Robinson., Moss S.M., Amar S., Balfour T.W. Randomized controlled trial of fecal occult blood for colorectal cancer // Lancet. 2006. N348 (9040). P. 77.
50. Horner M.J., Ries LAG., Krapcho M., Editors. SEER Cancer Statistics Review, 1975-2006 // National Cancer Institute. 2009.
51. Herbert A., Stein K., Bryant T.N., Breen C., Old P. The relationship between the frequency of invasive cervical cancer and screening interval: a five-year interval is too long // J Med Screen 1996. N3. P.140-145.
52. Hoffman M., Cooper D., Carrara H., Rosenberg L., Kelly J., Stander I., Williamson's AL., Denny L., G du Toit S. Shapiro Limited Pap screening is associated with reduced cancer risk cervix in South Africa // Int J Epidemiol. 2003. N32. P. 573-577.
53. Hewitson P., Glasziou P.P., Irwig L., Towler B., Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Available at: http://www.cochrane.org/ (accessed 01.01.2016).
54. Indep. UK panel on breast cancer, Lancet. 2012. P. 1778-86.
55. Kyung-Jin Min, Yoon Jae Lee, Mina Suh, Chong Woo Yoo, Myong Cheol Lim, Jaekyung Choi. The Korean guideline for cervical cancer screening // J Gynecol Oncol. 2015. N26. (3). P. 232–239.
56. Ko C.W., Sonnenberg A. Comparing risks and benefits of colorectal cancer screening in elderly patients // Gastroenterology. 2005. N129(4). P.1163-1170.
57. Lacey J.V. Jr1, Kreimer A.R., Buys S.S., Marcus P.M., Chang S.C., Leitzmann M.F., Hoover R.N. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer. 2009. P. 9- 84.
58. Lee J.K., Hong J.H., Kang the S., Kim D.Y., Kim B., Kim S.H. Practical recommendations for the early detection of cervical cancer in Korea. Korean Society of Gynecologic Oncology and Korean society Cytopathology edition 2012 // J Gynecol Oncol. 2013. N24. P. 186-203.
59. Leslea Pearson., Donna Fitzpatrick-Lewis., Donna Ciliska., Sankaranarayanan R., Jayant K., Muwonge R., Budukh AM., Hingmire S. HPV screening for cervical cancer in rural India // N Engl J Med. 2009. N360. P.1385-1394.
60. Mandel J.S., Church T.R., Bond J.H., Ederer F., Geisser M.S., Mongin S.J. Effect of faecal occult blood screening on the incidence of colorectal cancer // N Engl J Med. 2009. N343 (22). P. 1603.
61. Moyer V.A. US Preventive Services Task Force. Screening for cervical cancer: US Preventive recommendation statement // Services task Force Ann Intern Med. 2012. N156. P. 880-891.
62. Moura E.C.1, Claro R.M. Estimates of obesity trends in Brazil, 2006-2009 // Int J Public Health. 2012. № 57(1). Р.127-33.
63. Newschaffer C.J., Otani K., McDonald M., Penberthy L.T. Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort // J Natl Cancer Inst. 2000. N92. P. 613-621.
64. National Institute for cancer control national incidence of cancer in 2012, Korea Goyang: The Ministry of Health and Social Welfare. 2014. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510341/ (accessed 01.01.2016).
65. Kalager M., Adami H.O. Overdiagnosis of invasive cancer due to mammography screening: results from the Norwegian screening programme //Ann. Intern. Med. 2012. 156 (7) P. 491.
66. National Intelligence Cancer Network. Colorectal cancer survival stage - NCIN briefing data, 2009. 2011 October 4. Available from: http://www.ncin. org.uk/publications/data_briefings/colorectal_cancer (accessed 01.01.2016).
67. Nancy N., Baxter, Meredith A., Lawrence F. Association of Colonoscopy and Death From Colorectal Cancer: A Population-Based. Case–Control Study // MPH Annals of Internal Medicine 2016. N1. P.1-9.
68. Nelson H.D., Fu R., Cantor A., Pappas M., Daeges M., Humphrey L. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation // ACP Journal Club. 2016. 12.
69. Olsen A.H., Lynge E. Breast cancer mortality in Norway after the introduction of mammography screening // Int. J. Cancer. 2013. P. 208-14.
70. Philippe Autier. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database // Br. Med. J. 2010. P. 3620.
71. Paajanen H., Varjo R. Effect of screening mammography on surgery of breast cancer in Finland: a population - based analysis during the years 1985-2004 // Ann. Surg. 2006. 72. P.167-71.
72. Puliti D., Duffy S.W., Maccinesi G. Overdiagnosis in mam- mographic scraaning for breast cancer in Europe // J. Med. Screen. 2012. P. 42-56.
73. Prostate Cancer Screening: A Review of the Guidelines. Source Ottawa (ON): Canadian Agency for Drugs and Technologies in Health // CADTH Rapid Response Reports. 2013.
74. Rosen L., Bub D.S., Reed J.F., Nastasee S.A. Bleeding following colonoscopic polypectomy // Dis Colon intestine. 1993. N36. (12). P.1126-1131.
75. Sandra R. Distelhorst., James F. Cleary., Patricia A Ganz., Nuran Bese., Rolando Camacho-Rodriguez., Fatima Cardoso., Henry Ddungu. Optimisation of the continuum of supportive and palliativecare for patients with breast cancer in low-income and middle-income countries // Global Summit on Supportive Care and Quality of Life 2014. The lancet oncology. 2016. N3. P. 137-147.
76. Siegel R., Ma J., Z Zou, Jemal A. Cancer Statistics 2014 Italian, Cancer J Clin. 2014. N64. (1). P. 9-29.
77. Sasieni P.D., Cuzick J., Lynch-Farmery E. Assessment of the effectiveness of screening using the Pap audit histories of women with and without cervical cancer. National Coordination Network for cervical screening, the Working Group // Br J Cancer. 2008. N73. P. 1001-1005.
78. Sasieni P.J., Adams Cuzick J. The use of cervical screening at different ages: audit data screening UK stories // Br J Cancer. 2009. N89. P. 88-93.
79. Sasieni P., Castañón A., Cuzick J. The effectiveness of cervical screening with age. The population-based case-control study of prospectively recorded data // BMJ. 2009. P. 339.
80. Sasieni P., Castañón A., Cuzick J. Screening and cervical adenocarcinoma // Int J Cancer. 2009.
81. Schröder F.H., Hugosson J., Roobol M.J. Screening and prostate-cancer mortality in a randomized European study // N Engl J Med. 2009. N360. P. 1320-1328.
82. The cancer genome atlas network. Comprehensive molecular portraits of human breast tumors // Nature. 2012. P. 61-70.
83. The National Cancer Institute. Surveillance Epidemiology and End Results. SEER Stat sheets // Cancer of the colon and rectum 2010. Available from:http://seer.cancer.gov/statfacts/html/ colorect.html (accessed 01.01.2016).
84. The Advisory Committee of the Australian health care technology. Screening for colorectal cancer // Canberra Commonwealth Department of Health and Services. 2009. N6.
85. The Australian Institute of Health and Welfare and the Australian Government Department of Health stareniya.Natsionalnaya bowel cancer program: annual report 2009 data monitoring and addition 2010 // Cancer Series. 2010. N57.
86. The Royal Australian College of General Practitioners. Guidelines for prevention activities in general practice // Early detection of cancer. 2012. P. 60-72.
87. Towler B.P., Irwig L., Glasziou P. Systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult // BMJ 2009. 3N17. P. 559-65.
88. Thigpen S.C., Geraci SA. Cancer Screening 2016 // J Med Sci. 2016 N352. (5). P. 493-501.
89. Updated Recommendations on Colorectal Cancer Screening 2010 Burden of Colorectal Cancer in Hong Kong. 2012. Available at: http://www.chp.gov.hk /files/pdf/recommendations _on_crc_screening_2012.pdf (accessed 01.01.2016).
90. Use of mammography in women aged 40 years and older by selected characteristics:. United States, selected years 1987-2010 National Center for Health Statistics. 2015. Available at: www.cdc.gov/nchs/data/hus/2013/083.pdf~~ pobj November (accessed 01.01.2016).
91. U.S. Preventive Services task Force Recommendation Statement // Ann. Intern. Med. 2009. P. 716-26.
92. Vale D.B., Sauvaget C., Muwonge R. Disparities in time trends of cervical cancer mortality rates in Brazil Cancer Causes & Control 2016. N27. P. 889–896.
93. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S. Prevention of colorectal cancer by colonoscopic polyp study polipektomii.Natsionalny working groups // N Engl J Med. 2016. N329. (27). P.1977.
94. Whitlock E.P., Lin JS., Liles E., Beil TL., Fu R. Colorectal cancer screening: a targeted, updated systematic review for the US ed Preventive Services Task Force Ann Intern M. 2008. N149. (9). P. 638-658.
References:
1. Alieva T.M. Ckrining raka sheiki matki oshibki v diagnostike i puti ikh preduprezhdeniya [Ckrining cervical cancer еrrors in diagnosis and ways of their prevention]. Vestnik AGIUV [Bulletin AGIUV]. 2013, рр. 24-27.
2. Zhylkaidarova A.Zh. Rezul'taty skriningov zlokachestvennykh novoobrazovanii po itogam 2015 goda [By screening of malignant tumors on the basis of 2015]. SKDO KazNIIOiR [SKDO KazIOR]. 2015. http://onco.kz/node/14 (accessed: 01.01.2016)
3. Instruktsiya po provedeniyu profilakticheskikh meditsinskikh osmotro v otdel'nykh kategorii vzroslogo naseleniya putem vyborochnykh skriningovykh obsledovaniihttp [Instruktsiyapo the preventive medical osmotrovotdelnyh categories of adult population by random screening obsledovaniyhttp]. Metodicheskoe ukazaniya [Methodical instructions]. Available at: Online.zakon.kz (accessed: 01.01.2016)
4. Kaidarov B.K., Baltaev N.A., Afonin G.A. Zabolevaemost' kolorektal'nym rakom i sostoyanie khirurgicheskoi pomoshchi onkologicheskim bol'nym s dannoi patologiei [The incidence of colorectal cancer and the condition of surgical care to cancer patients with this pathology]. Onkologiya i radiologiya Kazakhstana [Oncology and Radiology of Kazakhstan]. 2011, № 4. pp. 37-40.
5. Komarova L.E. Covremennoe sostoyanie skriningovykh programm v onkologii [Current status of screening programs in oncology]. Possiiskii onkologicheskii zhurnal [Journal of Oncology] Moscow. 2013, N 5. pp. 48-51. [in Russian]
6. Komarova L.E. Sovremennoe sostoyanie skriningovykh programm v onkologii [The current state of screening programs in oncology]. Rossiiskii onkologicheskii zhurnal [Russian Journal of Oncology]. 2013. № 5. p. 48-51. [in Russian]
7. Kaprin A. D., Starinskij V.V, Petrova G. V. Zlokachestvennye novoobrazovanija v Rossii v 2012 godu zabolevaemost' i smertnost' [Malignancies in Russia in 2012 morbidity and mortality]. Kniga. red.M: FGBU «MNIOI im. P. A. Gercena» Minzdrava Rossii [book. red.M: FGBI "MNIOI them. PA Hertzen "Russian Ministry of Health]. 2014, p. 250. [in Russian]
8. Кazaкstan Respublikasynyң khalқyna onkologiyalyқ kоmek kоrsetetіn densaulyқ saқtau uiymdarynyn kyzmetі turaly erezhenі bekіtu turaly 2011 zhylgy 12 tamyzdagy № 540 bұiryғyna өzgerіster men tolyқtyrular engіzu turaly [Order № 540 health care organizations that provide cancer care services of the Republic of Kazakhstan]. Available at: http://adilet.zan.kz/rus (accessed: 01.01.2016)
9. Кazakstan Respublikasynda onkologiyalyқ komektі damytudy 2012 - 2016 zhyldarғa arnalғan baғdarlamasyn bekіtu turaly Kazakstan Respublikasy Үkіmetіnіn 2014 zhylgy 30 zheltoksandaғy № 1410 қaulysy. [The program Develop programs on cancer during the years 2012 and 2016]. Kazakstan. 2014. URL: https://www.google.kz/ (accessed: 01.01.2016)
10. Nurgalieva T.A. Vyyavlyaemost' zlokachestvennykh novoobrazovanii v skrininge raka sheiki matki [The detection of malignant neoplasms in screening for cervical cancer]. Nauka i zdravookhraneniya [Science and Health] 2012. №4. C.80-82.
11. Navesova V.Sh., Arybzhanov D.T., Tumenbaeva Zh.S., Kaskabaev A.U., Maklakova E.E. Rezul'taty mammograficheskogo skrininga raka molochnoi zhelezy v Yuzhnom –Kazakhstane [The results of mammographic screening for breast cancer in South -Kazahstane]. Sibirskii onkologicheskii zhurnal [Siberian Journal of Oncology]. 2009, №2. pp.1141-142.
12. Ob utverzhdenii standarta organizatsii okazaniya pervichnoi medikosanitarnoi pomoshchi v Respublike Kazakhstan. [Ob approval standard organization of primary medikosanitarnoy aid in the Republic of Kazakhstan]. 2016, №4. Available at: https://www.google.kz/ (accessed: 01.01.2016)
13. Ob utverzhdenii Pravil provedeniya profilakticheskikh meditsinskikh osmotrov tselevykh grupp naseleniya Prikaz i.o. Ministra zdravookhraneniya Respubliki Kazakhstan 2009. 10 noyabrya № 685 [On approval of rules for preventive medical examinations of the target population // Order of Acting Minister of Health of the Republic of Kazakhstan on November 10 2009. № 685]. Available at: https://www.google.kz/ (accessed: 01.01.2016)
14. Prikaz Ministra zdravookhraneniya Respubliki Kazakhstan ot 16 marta 2011 goda №145 Ob utverzhdenii Pravil provedeniya profilakticheskikh meditsinskikh osmotrov tselevykh grupp naseleniya [Order of the Minister of Health of the Republic of Kazakhstan dated 16 March 2011 №145 On approval of Rules of carrying out of preventive medical examinations of the target population]. Available at: https://www.google.kz/ (accessed: 01.01.2016)
15. Rakhypbekov T.K., Zhakipova A.A., Ban' T.P. Vyyavlyaemost' zlokachestvennykh novoobrazovani v skrininge molochnoi zhelezy [The detection of malignant tumors in the breast screening]. Nauka i zdravookhranenie [Science and Health]. 2010, № 1. pp. 212-214.
16. Rezul'taty skrininga raka molochnoi zhelezy po Aktyubinskoi oblasti za 2011 god [Results against Brest cancer screening along Aktyubensk]. Batys Қazaқstan meditsina zhurnaly [Medical Journal of West Kazakhstan region]. 2012, №2. P. 34.
17. Turbekova M.N., Egeubaeva S.A. Sovremennye podkhody k rannemu vyyavleniyu kolorektal'nogo raka (literaturnyi obzor) [Modern approaches to the early detection of colorectal cancer (literature review)]. Vestnik KAZNMU. [Bulletin KazNMU]. 2012, №4. pp. 89-94
18. Tashtemirova O.G., Tergeusizov S.M., Tergeusizova Sh.A., Tashtemirov K.K., Zhaltyrov R.L., Zhakupova G.A. Rol' skriningovogo issledovaniya v diagnostike zlokachestvennykh novoobrazovanii zheludochno-kishechnogo trakta [The role of screening in the diagnosis of malignant tumors of the gastrointestinal tract]. Nauka i zdravookhraneniye [Science & Healthcare]. 2014, №4. pp. 94-96
19. Tazhibayeva K.N. Zhanabaev N.S. Kerimov R.A. Buleshov M.A. Ontүstіk Kazakstan oblysynda turgyndar arasyndagy onkologiyalyk aurulardyn skrining tәsіlіmen anyktaluynyң kazіrgі tandaғy zhandaiy [South Kazakhstan region, measured by means of cancer screening among the population]. Vestnik KazNMU [Bulletin KazNMU]. 2015, №4. pp.137-139.
20. Turgunov M.A. Tsentr formirovaniya zdorovogo obraza zhizni po Severo-kazakhstanskoi oblasti [Center for Healthy Lifestyles in the North-Kazakhstan region]. Available at: http://sko-zozh.kz/skrining-raka-predstatelnoj-zhelezy-v-rk. (accessed: 01.01.2016)
21. Kholmatova K.K., Kharkova O.A., Grjibovski A.M. Klassifikacia nauchnyh issledovanij v zdravoohranenii [Types of research in health sciences]. Ekologiya cheloveka [Human Ecology]. 2016, N1. pp. 57–64. [in Russian]
22. Kholmatova K. K., Gorbatova M. A., Kharkova O. A., Grjibovski A. M. Poperechnye issledovanija: planirovanie, razmer vyborki, analiz dannyh [Cross-sectional studies: planning, sample size, data analysis]. Ekologiya cheloveka [Human Ecology]. 2016, N2. pp. 49–56. [in Russian]
23. Kholmatova K.K., Kharkova O.A., Grjibovski A.M. Osobennosti primenenija kogortnyh issledovanij v medicine i obshhestvennom zdravoohranenii [Conort studies in medicine and public health]. Ekologiya cheloveka [Human Ecology]. 2016, N4. pp. 56–64. [in Russian]
24. Kholmatova K.K., Grjibovski A.M. Primenenie issledovanij «sluchaj-kontrol'» v medicine i obshhestvennom zdravoohranenii [ Case–control studies in medicine and public health]. Ekologiya cheloveka [Human Ecology]. 2016, N8. pp. 53–60. [in Russian]
25. Kholmatova K.K., Grjibovski A.M. Panel'nye issledovanija i issledovanija trenda v medicine i obshhestvennom zdravoohranenii [ Panel-and studies in medicine and public health]. Ekologiya cheloveka [Human Ecology]. 2016, N10. pp. 57–64. [in Russian]
26. Kholmatova K.K., Kharkova O.A., Grjibovski A.M. Jeksperimental'nye issledovanija v medicine i zdravoohranenii: planirovanie, obrabotka dannyh, interpretacija rezul'tatov [Experimental studies in medicine and public health: planning, data analysis, interpretation of results]. Ekologiya cheloveka [Human Ecology]. 2016, N11. pp. 50–58. [in Russian]
27. Shalgumbaeva G.M. Otsenka effektivnosti provedeniya skriningovoi programmy po rannemu vyyavleniyu rakovykh i predrakovykh zabolevanii sheiki matki po Vostochno-Kazakhstanskomu regionu i puti uluchsheniya ee kachestva: avtoref. dis. ... PhD doktor. [Evaluating the effectiveness of the screening program for early detection of cancerous and pre-cancerous cervical disease on the East Kazakhstan region and ways to improve its quality: Abstract. Dis. ... PhD Doctor. Families]. Сemey. 2014, 38 р.
28. Shibanova A.I., Eleubaeva Zh.B., Sabitov D., Kashmagambetova M. Sh., Karimova N. G., Zhylkaidarova A. Zh., Organizatsiya skrininga raka sheiki matki v Respublike Kazakhstan i puti sovershenstvovaniya [Organization of cervical cancer screening in the Republic of Kazakhstan and ways to improve theRepublic of Kazakhstan and ways to improve]. Oncology Radiology Kazakhstana [Oncology and Radiology of Kazakhstan]. 2016, N10. p. 53.
29. Alanbay I., Emre Karaşahin K., Ozturk M.,Cemal Yenen. M. The cytohistological discrepencies of cervicovaginal smears and hpv status. ESGO eAcademy Alanbay i. 2015, Oct 24. 107109.
30. Anand S.S., McLaughlin S.J., Chen F., Hayes I.P., Hunter A., Skinner I.J. Pervonachalnoe impact colon cancer screening program of National Australia. Med J Aust. 2009, pp. 378-81.
31. Amy J Blatt, Ronald Kennedy, Ronald D Luff. Comparison of cervical cancer screening results among 256.648 women in several clinical practice. Cancer Cytopathol. 2015, N123. (5). pp. 282.
32. Andrae B., Kemetli L., Sparen P., Silfverdal L., Strander B., Ryd W., Dillner J., Törnberg S. Screening-preventable cervical cancer risk: a national audit data in Sweden. J Natl Cancer Inst. 2008, N100. pp.622- 629.
33. Andriole G.L., Crawford E.D., Grubb RL. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009, N360. pp. 1310-1319.
34. Bretthauer M., Kalager M. Priciples effectiveness and caveats in screening for cancer. Br. J. Surg. 2013, pp. 55-65.
35. Boyle P. Levin International Agency for Research on Cancer. World Report. 2008 Cancer.
36. Brenner H., Hoffmeister M., Birkner B. C. Diagnosis Stock guaiac-based fecal occult blood test in routine screening: analysis of the national. Official Journal of the European Union. 2003, p. 327.
37. By Jennifer S., Margaret A., Leslie A., Carolyn M., Elizabeth M. Screening for Colorectal Cancer US Preventive Services Task Force Recommendation Statement. American Medical Association. JAMA. 2016, N315. (23). pp. 2564-2575.
38. Baxter N., Meredith A. Goldwasser S. Association of Colonoscopy and Death From Colorectal Cancer. A Population-Based, Case–Control Study Nancy. MPH Annals of Internal Medicine. 2019, №1. pp. 1-9.
39. Canfield S. Annual screening for prostate cancer did not reduce mortality from prostate cancer. Evid Based Med. 2009, N14. pp. 104-105.
40. Dickinson J., Tsakonas E., Conner Gorber S., Lewin G. E. Canadian Task Force on Preventive Health Care. Shaw and other recommendations for screening cervical cancer. CMAJ. 2013, N185. pp. 35-45.
41. European Union Council. Recommendation of 2 December 2003 on Cancer Screening, 2003. European Union EN 2003, N12. p. 16.
42. Edwards B.K., Kohler B.A. Annual report to the nation on the state of cancer 1975-2006, featuring colorectal cancer trends and the effects of interventions. Risk factors, screening and treatment to reduce future morbidity cancer. 2010, N116. (3). pp. 544-573.
43. Evelyn P., Jennifer S. Lin, Margaret Piper, Leslie A. Perdue, Carolyn M. Rutter, Elizabeth M. Webber, Elizabeth O'Connor, Ning Smith, Whitlock Screening for Colorectal Cancer US Preventive Services Task Force Recommendation Statement. American Medical Association. JAMA. 2016, N315. (23). pp. 2564-2575.
44. Feb J., Dancourt V.S. The decrease of colorectal cancer mortality using fecal occult blood screening in the French controlled study. Gastroenterology. 2004, N126. (7). pp. 1674-1680.
45. Falk R.S., Hofvind S., Skaane P. Overdiagnosis among women attending a population-based mammography screen- ing programme. Int. J. Cancer. 2013, Jan 25.
46. GLOBOCAN 2008 International Agency for Research on Cancer. Kolorektalny morbidity and mortality from cancer in the world. 2008. 2011.
47. Soerjomataram F.J., Ervik I., Dikshit M, Eser R., Mathers S. Cancer incidence and mortality worldwide. International Agency for Research on Cancer. 2016, 22 January. Available at: http://globocan.iarc.fr, accessed (accessed 01.01.2016).
48. Harald Weedon-Fekjær, Pål R Romundstad, Lars J Vatten. Modern mammography screening and breast cancer mortality. population study. BMJ. 2014, p. 348.
49. Hardcastle J.D., Chamberlain J.O., the Robinson M.H., Moss S.M., Amar S., Balfour T.W. Randomized controlled trial of fecal occult blood for colorectal cancer. Lancet. 2006, N348 (9040). pp. 77.
50. Horner M.J., Ries LAG., Krapcho M., Editors. SEER Cancer Statistics Review, 1975-2006. National Cancer Institute. 2009.
51. Herbert A., Stein K., Bryant TN., Breen C., Old P. The relationship between the frequency of invasive cervical cancer and screening interval: a five-year interval is too long. J Med Screen. 2008, N3. pp.140-145.
52. Hoffman M., Cooper D., Carrara H., Rosenberg L., Kelly J., Stander I., Williamson's AL., Denny L., G du Toit S. Shapiro Limited Pap screening is associated with reduced cancer risk cervix in South Africa. Int J Epidemiol. 2009. N32. p. 573-577.
53. Hewitson P., Glasziou P.P., Irwig L., Towler B., Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Available at: http://www.cochrane.org/ (accessed 01.01.2016).
54. Indep. UK panel on breast cancer, Lancet. 2012, pp. 1778-86.
55. Kyung-Jin Min., Yoon Jae Lee., Mina Suh., Chong Woo Yoo., Myong Cheol Lim., Jaekyung Choi. The Korean guideline for cervical cancer screening. J Gynecol Oncol. 2015, N26. (3). pp. 232–239.
56. Ko C.W., Sonnenberg A. Comparing risks and benefits of colorectal cancer screening in elderly patients. Gastroenterology. 2005, N129(4). pp.1163-1170.
57. Lacey J.V., Kreimer A.R., Buys S.S., Marcus P.M., Chang S.C., Leitzmann M.F., Hoover R.N. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer. 2009, pp. 9- 84.
58. Lee J.K., Hong J.H., Kang the S., Kim D.Y., Kim B., Kim S.H. Practical recommendations for the early detection of cervical cancer in Korea. Korean Society of Gynecologic Oncology and Korean society Cytopathology edition 2012. J Gynecol Oncol. 2013, N24. pp. 186-203.
59. Leslea Pearson, Donna Fitzpatrick-Lewis, Donna Ciliska., Sankaranarayanan R., Jayant K., Muwonge R., Budukh A.M., Hingmire S. HPV screening for cervical cancer in rural India. N Engl J Med. 2009, N360. pp.1385-1394.
60. Mandel J.S., Church T.R., Bond J.H., Ederer F., Geisser M.S., Mongin S.J. Effect of faecal occult blood screening on the incidence of colorectal cancer. N Engl J Med. 2009, N343 (22). pp. 1603.
61. Moyer V.A. US Preventive Services Task Force. Screening for cervical cancer: US Preventive recommendation statement. Services task Force Ann Intern Med. 2012, N156. pp. 880-891.
62. Moura E.C.1, Claro R.M. Estimates of obesity trends in Brazil, 2006-2009. Int J Public Health. 2012, № 57(1). pp.127-33.
63. Newschaffer C.J., Otani K., Mc Donald M., Penberthy L.T. Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst. 2000, N92. pp. 613-621.
64. National Institute for cancer control national incidence of cancer in 2012, Korea Goyang: The Ministry of Health and Social Welfare. 2014. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510341/ (accessed 01.01.2016).
65. Kalager M., Adami H.O. Overdiagnosis of invasive cancer due to mammography screening: results from the Norwegian screening programme. Ann. Intern. Med. 2012, 156 (7) p. 491.
66. National Intelligence Cancer Network. Colorectal cancer survival stage - NCIN briefing data, 2009. 2011 October 4. Available from: http://www.ncin. org.uk/publications/data_briefings/colorectal_cancer (accessed 01.01.2016).
67. Nancy N., Baxter, Meredith A., Lawrence F., Association of Colonoscopy and Death From Colorectal Cancer: A Population-Based. Case–Control Study. MPH Annals of Internal Medicine 2016, N1. pp.1-9.
68. 68. Nelson H.D., Fu R., Cantor A., Pappas M., Daeges M., Humphrey L. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation. ACP Journal Club. 2016, 12.
69. Olsen A.H., Lynge E. Breast cancer mortality in Norway after the introduction of mammography screening. Int. J. Cancer. 2013, pp. 208-14.
70. 70. Philippe Autier. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. Br. Med. J. 2010, p. 3620.
71. Paajanen H., Varjo R. Effect of screening mammography on surgery of breast cancer in Finland: a population - based analysis during the years 1985-2004. Ann. Surg. 2006, 72. pp.167-171.
72. 72. Puliti D., Duffy S. W., Maccinesi G. Overdiagnosis in mam- mographic scraaning for breast cancer in Europe. J. Med. Screen. 2012, pp. 42-56.
73. Prostate Cancer Screening: A Review of the Guidelines. Source Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. CADTH Rapid Response Reports. 2013.
74. Rosen L., Bub D.S., Reed J.F., Nastasee S.A. Bleeding following colonoscopic polypectomy. Dis Colon intestine. 2009, N36. (12). pp.1126-1131.
75. Sandra R. Distelhorst, James F. Cleary, Patricia A Ganz, Nuran Bese, Rolando Camacho-Rodriguez, Fatima Cardoso, Henry Ddungu. Optimisation of the continuum of supportive and palliativecare for patients with breast cancer in low-income and middle-income countries. Global Summit on Supportive Care and Quality of Life 2014. The lancet oncology. 2016. N3. P. 137-147.
76. Siegel R., Ma J., Z Zou., Jemal A. Cancer Statistics 2014 Italian, Cancer J Clin. 2014, N64. (1). pp. 9-29.
77. Sasieni P.D., Cuzick J., Lynch-Farmery E. Assessment of the effectiveness of screening using the Pap audit histories of women with and without cervical cancer. National Coordination Network for cervical screening, the Working Group. Br J Cancer. 2008, N73. pp. 1001-1005.
78. Sasieni P.J., Adams Cuzick J. The use of cervical screening at different ages: audit data screening UK stories. Br J Cancer. 2009, N89. pp. 88-93.
79. Sasieni P., Castañón A., Cuzick J. The effectiveness of cervical screening with age. The population-based case-control study of prospectively recorded data. BMJ. 2009. p. 339.
80. Sasieni P., Castañón A., Cuzick J. Screening and cervical adenocarcinoma. Int J Cancer. 2009.
81. Schröder F.H., Hugosson J., Roobol M.J. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009, N360. pp. 1320-1328.
82. The cancer genome atlas network. Comprehensive molecular portraits of human breast tumors. Nature. 2012, pp. 61-70.
83. The National Cancer Institute. Surveillance Epidemiology and End Results. SEER Stat sheets. Cancer of the colon and rectum 2010. Available from: http://seer.cancer.gov/statfacts/html/colorect.html (accessed 01.01.2016).
84. The Advisory Committee of the Australian health care technology. Screening for colorectal cancer. Canberra Commonwealth Department of Health and Services. 2009, N6.
85. The Australian Institute of Health and Welfare and the Australian Government Department of Health stareniya. Natsionalnaya bowel cancer program: annual report 2009 data monitoring and addition 2010, Cancer Series. 2010, N57.
86. The Royal Australian College of General Practitioners. Guidelines for prevention activities in general practice. Early detection of cancer. 2012, pp. 60-72.
87. Towler B.P., Irwig L., Glasziou P. Systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ. 2009, N17. pp. 559-65.
88. Thigpen S.C.1, Geraci S.A. Cancer Screening 2016. J Med Sci. 2016, N352. (5). pp. 493-501.
89. Updated Recommendations on Colorectal Cancer Screening 2010 Burden of Colorectal Cancer in Hong Kong. 2012. Available at: http://www.chp.gov.hk /files/pdf/recommendations _on_crc_screening_2012.pdf (accessed 01.01.2016).
90. Use of mammography in women aged 40 years and older by selected characteristics: United States, selected years 1987-2010 National Center for Health Statistics. 2015. Available at: www.cdc.gov/ nchs/ data/hus/ 2013/083. pdf~~ pobj November (accessed 01.01.2016).
91. U.S. Preventive Services task Force Recommendation Statement. Ann. Intern. Med. 2009, pp. 716-26.
92. Vale D.B., Sauvaget C., Muwonge R. Disparities in time trends of cervical cancer mortality rates in Brazil. Cancer Causes & Control. 2016, N27. pp. 889–896.
93. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S. Prevention of colorectal cancer by colonoscopic polyp study polipektomii.Natsionalny working groups. N Engl J Med. 2016, N329. (27). p.1977.
94. Whitlock E.P., Lin J.S., Liles E., Beil T.L., Fu R. Colorectal cancer screening: a targeted, updated systematic review for the US ed Preventive Services Task Force. Ann Intern M. 2008, N149. (9). pp. 638-658.
Number of Views: 391
Category of articles:
Reviews
Bibliography link
Булешов М.А., Тажибаева К.Н., Булешова А.М., Гржибовский A.М. Оценка эффективности скрининга онкологических заболеваний у трудоспособного населения за рубежом и в Казахстане. Систематический обзор / / Наука и Здравоохранение. 2016. № 6. С. 123-145. Buleshov М.A., Tazhibayeva K.N., Buleshovа A.М., Grjibovski A.M. Evaluating the effectiveness of screening for cancer in the population of working abroad and in Kazakhstan. Systematic review. Nauka i Zdravookhranenie [Science & Healthcare]. 2016, 6, pp. 123-145. Булешов М.А., Тажибаева К.Н., Булешова А.М., Гржибовский A.М. Қазақстанда және Шетелде еңбек ету жасындағы тұрғындар арасында ұйымдастырылатын онкологиялық скринингтің тиімділігін бағалау нәтижелері. Жүйелі әдебиеттік шолу / / Ғылым және Денсаулық сақтау. 2016. № 6. Б. 123-145.Related publications:
INTERRELATION OF INTRAABDOMINAL HYPERTENSION AND MARKERS OF GASTROINTESTINAL TRACT INJURY IN PATIENTS WITH MULTIORGAN DYSFUNCTION
DRUG-INDUCED LIVER INJURY AND GENDER DIFFERENCES
QUALITY OF LIFE IN PRIMARY BILIARY CHOLANGITIS AND ITS ASSESSMENT
DIAGNOSTIC AND THERAPEUTIC LAPAROSCOPY FOR ABDOMINAL INJURIES. REVIEW
METHODS FOR SCHOOL-AGE CHILDREN NUTRITIONAL STATUS ASSESSMENT: FOCUS ON ANTHROPOMETRIC PARAMETERS. A REVIEW.